Abstract

  Lots of medicinal plants have shown the potential for Treatment of diabetes mellitus (DM). We have already reviewed the role of lot of plants as well as plant products related to this that can be utilized in future to prevent the cost and side effects of the oral hypoglycaemic agents like monoterpenes that get produced in various organisms including bacteria, fungi, plants and animals, role of protein tyrosine phosphatase 1B (PTP1B) inhibitors (produced by marine organisms was plants, role of herbs and spices, Anthocyanins are present in berries which include blackberries, bilberries, chokeberries, elder berries, cranberries and raspberries that are the richest sources of anthocyanins. Many other highly colored fruits like strawberries, black currant, cherry, grape, coloured cabbage, eggplant and radish also have high levels of anthocyanins, thus it is important to include these in the low-calorie diets plans to improve insulin resistance (IR) along with helping in weight reduction. Here we further report on two potential new compounds for therapy of DM, like Trigonella foenum-graecim extract along with ursolic acid another pentacyclic terpenoid.

Keywords: Trigonella foenum-graecim Extract; Ursolic Acid; Diabetes Mellitus; Plant Products

Bibliography

1. Kulvinder Kochar Kaur., et al. “Monoterpenes - A Class of Terpenoid Group of Natural Products as a Source of Natural Antidiabetic Agents in the Future -A Review”. CPQ Nutrition4 (2019): 01-21.
2. Kulvinder Kochar Kaur., et al. “Development of protein tyrosine phosphatase 1B (PTPIB) Inhibitors from marine sources and other natural products-Future of Antidiabetic Therapy : A Systematic Review”. Korean Journal of Food and Health Convergence3 (2019): 21-33.
3. Kulvinder Kochar Kaur., et al. “Bioactive Compounds within Herbs and Spices Contributing to Anti Diabetic Action in Type2 Diabetes Mellitus (T2DM) - A Short Communication". Acta Scientific Nutritional Health1 (2020): 88-92.
4. Kulvinder Kochar Kaur., et al. “Role of Natural Products in the Treatment of Diabesity with Mechanism of Action-A Small Communication". Acta Scientific Nutritional Health7 (2019): 140-142.
5. Kulvinder Kochar Kaur., et al. “Potential Role of Biochemical Components of Schisandra chinensis for Prevention and Treatment of Obesity, Type2 Diabetes Mellitus, Cancer and Prevention of Aging - A Systematic Review". Acta Scientific Nutritional Health8 (2019).
6. Kulvinder Kochar Kaur., et al. “Importance of simultaneous treatment of obesity and diabetes mellitus: A sequelae to the understanding of diabesity-A review”. Obesity Research – Open Journal 1 (2019): 1-10.
7. Birhane G. “Effect of processing on phytochemicals and nutrients composition of fenugreek (Trigonella foenum-graecum L.), and development of value added products (Doctoral dissertation)”. AAU (2012).
8. Meghwal M and Goswami TK. “A review on the functional properties, nutritional content, medicinal utilization and potential application of fenugreek”. Journal of Food Processing and Technology9 (2012).
9. Prasanna M. “Hypolipidemic effect of fenugreek: diabetic patients: A clinical study”. Indian Journal of Pharmacology 32 (2000): 34-36.
10. Campbell-Tofte JI., et al. “Harnessing the potential clinical use of medicinal plants as anti-diabetic agents”. Botanics: Targets and Therapy 2 (2012): 7-19.
11. Sauvaire Y., et al. “4-Hydroxyisoleucine: a novel amino acid potentiator of insulin secretion”. Diabetes 2 (1998): 206-210.
12. Gupta A. “Effect of Trigonella foenumgraecum (fenugreek) seeds on glycaemic control and insulin resistance in type 2 diabetes mellitus: a double blind placebo controlled study”. The Journal of the Association of Physicians of India 49 (2001): 1057-1061.
13. Dangi RS., et al. “Assessment of genetic diversity in Trigonella foenum-graecum and Trigonella caerulea using ISSR and RAPD markers”. BMC Plant Biology1 (2004): 13.
14. , et al. “Antidiabetic Effect of Fenugreek Seed Powder Solution (Trigonella foenum-graecum L.) on Hyperlipidemia in Diabetic Patients”. Journal of Diabetes Research (2019): 8.
15. Sandjo LP., et al. “Triterpenes and Steroids from the Medicinal Plants of Africa”. Elsevier: Amsterdam, The Netherlands (2013): 135-202.
16. Babalola I T and Shode F O. “Ubiquitous ursolic acid: A potential pentacyclic triterpene natural product”. Pharmacognosy2.
17. Nascimento PGD., et al. “Antibacterial and Antioxidant Activities of Ursolic Acid and Derivatives”. Molecules 19 (2014): 1317-1327.
18. Khusnutdinova E F., et al. “Inhibition of Alpha-Glucosidase by Synthetic Derivatives of Lupane, Oleanane, Ursane and Dammarane Triterpenoids”. Natural Product Communications 11 (2016): 33-35.
19. Wu PP., et al. “In vitro and in vivo evaluation of the antidiabetic activity of ursolic acid derivatives”. European Journal of Medicinal Chemistry 80 (2014): 502-508.
20. Wu P., et al. “Synthesis and Evaluation of Novel Triterpene Analogues of Ursolic Acid as Potential Antidiabetic Agent”. PLoS ONE 10 (2015): e0138767.
21. Yu SG., et al. “Ursolic acid derivative amelioratesstreptozotocin-induced diabestic bone deleterious e_ects in mice”. International Journal of Clinical and Experimental Pathology 8 (2015): 3681-3690.
22. Zhang T., et al. “Ursolic acid reduces oxidative stress to alleviate early brain injury following experimental subarachnoid hemorrhage”. Neuroscience Letter 579 (2014): 12-17.
23. Lo SH., et al. “Ursolic acid activates the TGR5 receptor to enhance GLP-1 secretion in type 1-like diabetic rats”. Naunyn-Schmiedeberg's Archives of Pharmacology 390 (2017): 1097-1104.
24. Mlala S., et al. “Ursolic acid and its derivatives as Bioaxctive Agents”. Molecules 24 (2019): 2751.

Copyright: © 2021 Kulvinder Kochar Kaur., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.